Type 1 diabetes (T1D) is regarded as an organ-specific autoimmune disease, during which innate and adaptive immune cells comprising CD4+ and CD8+ T cells, B cells, and antigen-presenting cells (APCs) are involved in a dynamic progression of inflammation of the islet contributing to the loss of pancreatic β cells [1]. The gene discussed is CD4; the disease is type 1 diabetes mellitus.